Health information technology company Vitamin Chas been selected to join the first cohort of companies in Emergence, a health information technology and medtech business accelerator located in Alpharetta, Georgia. Vitamin C will be focusing on reaching "investable" status by the completion of Emergence's 12-week Business Acceleration Program.

Vitamin C provides a software-based "communication supplement" (hence the name Vitamin C) to physician practices and other patient-centric organizations to increase revenue through the automated identification, contact and engagement of patients eligible for additional services, screenings and procedures. 

"Vitamin C's position in the company development lifecycle is squarely in the sweet spot of Emergence's target company recruiting profile -- beyond the incubator stage, with a developed product, beginning commercialization," said Chris Hooper, CEO of Emergence. "Vitamin C is changing the way health is managed and Emergence is preparing them to succeed. Emergence is dedicated to accelerating companies in Georgia to build the state's economy, enhance metro Atlanta's leadership position in health technologies and create high-end jobs for Georgia's college and technical school graduates."

"I am thrilled to be joining Emergence, Georgia's up-and-coming HIT and medtech accelerator," said Vitamin C CEO, Osama Hashmi. "In our first few weeks in the business acceleration program we have benefited first-hand from seasoned mentors and Emergence staff who are solidifying our company's positioning for our customers and investors. It truly excites me to be getting the help Emergence is providing so that we can take the next steps towards successful commercialization."